Stockreport

Organogenesis Provides Update on Second Phase 3 ReNu® Study

Organogenesis Holdings Inc. - Class A  (ORGO) 
Last organogenesis holdings inc. - class a earnings: 3/9 04:05 pm Check Earnings Report
PDF Company maintains confidence in ReNu as innovative pain management therapy Second Phase 3 trial demonstrates numerical improvement in baseline pain reduction ov [Read more]